Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Temporarily not available 1Completed 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1

Conditions

Sarcoma, Ewing 4Ovarian Neoplasms 4Uterine Neoplasms 2Uterine Cervical Neoplasms 2Sarcoma 2Neoplasms 2Melanoma 2Carcinoma, Non-Small-Cell Lung 2Rare Diseases 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Connective and Soft Tissue 1Neoplasms, Connective Tissue 1Neoplasms, Bone Tissue 1Neoplasms by Histologic Type 1Lung Neoplasms 1Liver Neoplasms 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

pembrolizumab 44Carboplatin 28Cisplatin 26Paclitaxel 24Bevacizumab 21human papillomavirus vaccine, L1 type 16, 18 16Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14atezolizumab 11Papillomavirus Vaccines 11Nivolumab 10tisotumab vedotin 8Vaccines, Synthetic 8Gemcitabine 8Colposcopy 8Topotecan 7fludarabine 6Vaccines 6Injections 6Cyclophosphamide 6spartalizumab 5balstilimab 5Pemetrexed 5Irinotecan 5Fulvestrant 5Docetaxel 5zimberelimab 4durvalumab 4Vinorelbine 4Ipilimumab 4Interleukin-2 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Uterine Cervical Neoplasms × FANG vaccine × Clear all
NCT03842865 2025-06-05

Expanded Access of Vigil in Solid Tumors

Gradalis, Inc.

Temporarily not available
GynecologicSarcoma

Uterine Cervical Neoplasms, Ovarian Neoplasms, Sarcoma, Ewing, Uterine Neoplasms

NCT03073525 2023-04-05

A Trial of Atezolizumab and Vigil in Patients With Advanced Gynecological Cancers

Gradalis, Inc.

Phase 2 Completed
25 enrolled 15 charts
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡